Bugünkü hisse fiyatı Alexion Pharmaceuticals (ALXN)

Alexion Pharmaceuticals is an American pharmaceutical company, a manufacturer of medicines for rare diseases and an active participant in studies of the immune system. Alexion Pharmaceuticals was founded in 1992. It became widely known after the development of Soliris, a drug for treating diseases that were considered incurable. In 2011, it was added to NASDAQ-100: Acquired Synageva BioPharma for $ 8.4 billion in 2015. Before the deal, Alexion Pharmaceuticals was valued at $ 34 billion, after acquiring Synageva BioPharma, the company’s shares rose 800% in 5 years.